Cardiomyopathies, Arrhythmias, and Sudden Death General Panel [251 genes]

It includes all diseases that can produce arrhythmias (high predisposition to sudden death), either with or without the presence of structural heart disease. As such, it includes all cardiomyopathies, channelopathies, and cardiac conduction diseases.

  • This panel is mainly aimed at the diagnosis of cases where it is not possible to establish a clearly defined phenotype, but where cardiac arrhythmias are the main manifestation.
  • It is mainly intended for subjects with personal or familial history of sudden death with unknown origin or subjects with ventricular fibrillation of unknown origin that meet the above-mentioned characteristics.

Request study Informed consent
Steps to follow
Steps to follow

How to order

1. Download & fill out

Please cover as many fields as possible in both documents

2. Sample collection

Three sample types: saliva, peripheral blood or genomic DNA

3. Pack the sample

Please pack the sample in a way to prevent leakage

4. Send the sample & the request

Please schedule the delivery for Mon–Thur: 8am – 5pm

5. Result: the report

Via: Client Site HIC / Client Site Imegen / Certified email

Ask for information
Solicita información de

Cardiomyopathies, Arrhythmias, and Sudden Death General Panel

  • *

Turnaround time (TAT): 4 weeks

Ref. S-201906399

Cardiomyopathies, Arrhythmias, and Sudden Death General Panel: View panel

It includes priority genes with a clear association with these diseases, secondary genes where the evidence is
lower, and candidate genes gathered from a systematic literature review.

  • ACTC1
  • BAG3
  • CACNA1C
  • CALM1
  • CALM2
  • CALM3
  • CASQ2
  • DES
  • DMD
  • DSC2
  • DSG2
  • DSP
  • EMD
  • FHL1
  • FHOD3
  • FLNC
  • GLA
  • JUP
  • KCNE1
  • KCNE2
  • KCNH2
  • KCNJ2
  • KCNQ1
  • LAMP2
  • LMNA
  • MYBPC3
  • MYH7
  • MYL2
  • MYL3
  • NKX2-5
  • PKP2
  • PLN
  • PRKAG2
  • PTPN11
  • RBM20
  • RYR2
  • SCN5A
  • TNNC1
  • TNNI3
  • TNNT2
  • TPM1
  • TRIM63
  • TTN
  • TTR
  • AARS2
  • ACAD9
  • ACADVL
  • ACTA1
  • ACTN2
  • AGK
  • AGL
  • AGPAT2
  • AKAP9
  • ALMS1
  • ALPK3
  • ANK2
  • ANO5
  • ATPAF2
  • CACNA1D
  • CACNA2D1
  • CACNB2
  • CAV3
  • COA5
  • COA6
  • COQ2
  • COX15
  • COX6B1
  • CRYAB
  • CSRP3
  • CTNNA3
  • DLD
  • DNAJC19
  • DOLK
  • DTNA
  • EYA4
  • FAH
  • FHL2
  • FKRP
  • FKTN
  • FOXRED1
  • GAA
  • GATA4
  • GATA5
  • GATA6
  • GFM1
  • GJA5
  • GLB1
  • GNB2
  • GNPTAB
  • GUSB
  • GYG1
  • HCN4
  • HFE
  • HRAS
  • IRX3
  • JPH2
  • KCND3
  • KCNE3
  • KCNE5
  • KCNJ5
  • KCNJ8
  • KLHL24
  • KRAS
  • LAMA2
  • LDLR
  • LIAS
  • LZTR1
  • MAP2K1
  • MAP2K2
  • MLYCD
  • MRPL3
  • MRPL44
  • MRPS22
  • MTO1
  • MYBPHL
  • MYOT
  • MYOZ2
  • MYPN
  • NF1
  • NRAS
  • PMM2
  • PPA2
  • PPCS
  • PRDM16
  • QRSL1
  • RAF1
  • RIT1
  • SCN1B
  • SCN2B
  • SCO2
  • SDHA
  • SGCD
  • SGCG
  • SHOC2
  • SLC22A5
  • SLC25A3
  • SNTA1
  • SOS1
  • SPEG
  • SURF1
  • TAZ
  • TBX20
  • TBX5
  • TCAP
  • TECRL
  • TMEM43
  • TMEM70
  • TNNI3K
  • TRDN
  • TRPM4
  • ZBTB17
  • A2ML1*
  • ABCC9*
  • AKT1*
  • ANK3*
  • ANKRD1*
  • ATP5F1E*
  • BRAF*
  • BSCL2*
  • C10orf71*
  • CALR*
  • CALR3*
  • CASZ1*
  • CAVIN1*
  • CAVIN4*
  • CBL*
  • CDH2*
  • CHRM2*
  • COL7A1*
  • CTNNA1*
  • CTNNB1*
  • DNM1L*
  • ELAC2*
  • FBXO32*
  • FGF12*
  • FXN*
  • GATAD1*
  • GJA1*
  • GPD1L*
  • GREM2*
  • GSK3B*
  • IDH2*
  • ILK*
  • ISM2*
  • JARID2*
  • KAT6B*
  • KCNA5*
  • KCND2*
  • KCNK17*
  • KLF10*
  • LAMA4*
  • LDB3*
  • LMOD2*
  • MAP3K8*
  • MEF2C*
  • MIB1*
  • MYH6*
  • MYLK2*
  • MYOM1*
  • NEBL*
  • NEXN*
  • NKX2-6*
  • NNT*
  • NONO*
  • NOS1AP*
  • NOTCH1*
  • NPPA*
  • NRAP*
  • OBSCN*
  • OPA3*
  • PDHA1*
  • PDLIM3*
  • PERP*
  • PHKA1*
  • PITX2*
  • PKD2*
  • PKP4*
  • PPP1CB*
  • PPP1R13L*
  • PSEN1*
  • PSEN2*
  • RANGRF*
  • RASA1*
  • RASA2*
  • RBM24*
  • RRAS*
  • SCN10A*
  • SCN3B*
  • SCN4B*
  • SGCA*
  • SGCB*
  • SLC25A4*
  • SLMAP*
  • SOS2*
  • SPRED1*
  • SPRY1*
  • SYNE1*
  • SYNE2*
  • SYNGAP1*
  • TGFB3*
  • TMEM175*
  • TMOD1*
  • TOR1AIP1*
  • TRIM54*
  • TSFM*
  • TXNRD2*
  • VCL*
  • WISP1*
  • WT1*
  • XK*
  • ZFHX3*

Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.

Related panels
Cardiomyopathies, Arrhythmias, and Sudden Death General Panel [251 genes]

This site is registered on wpml.org as a development site.